Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F George

Showing results (421-430 of 750) with videos related to

Pageof 75
Sort By:
The Journal of Organic Chemistry|May 4, 2016
Enantioselective Synthesis of 3,3-Difluoropyrrolidin-4-ol, a Valuable Building Block in Medicinal ChemistryChong Si, Kevin R Fales, Alicia Torrado, et al.
Elife|July 5, 2022
Single-cell glycomics analysis by CyTOF-Lec reveals glycan features defining cells differentially susceptible to HIVTongcui Ma, Matthew McGregor, Leila Giron, et al.
Future Medicinal Chemistry|September 24, 2019
Synthesis and anticancer activity of some pyrido[2,3-<i>d</i>]pyrimidine derivatives as apoptosis inducers and cyclin-dependent kinase inhibitorsSafinaz E-S Abbas, Riham F George, Eman M Samir, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2015
Synthesis and QSAR study of novel anti-inflammatory active mesalazine-metronidazole conjugatesRoman N Naumov, Siva S Panda, Adel S Girgis, et al.
Transplantation|September 1, 2011
Ganciclovir transiently attenuates murine cytomegalovirus-associated renal allograft inflammationMasako Shimamura, Ute Saunders, Brian Rha, et al.
Transplantation|February 7, 2001
Enhanced allograft survival induced by posttransplant donor spleen cell infusion occurs via a mechanism that is distinct from the mechanism of enhancement by donor bone marrowD R Goldstein, T Chang, S D Sweeney, et al.
British Journal of Clinical Pharmacology|April 1, 1991
Ethnic differences in the pharmacokinetics of oral nifedipineC H Ahsan, A G Renwick, B Macklin, et al.
Clinical Pharmacokinetics|September 1, 1986
Effects of ischaemic heart disease, Crohn's disease and antimicrobial therapy on the pharmacokinetics of sulphinpyrazoneH A Strong, R Angus, J Oates, et al.
Bioorganic Chemistry|November 1, 2018
Synthesis and anti-proliferative activity of some new quinoline based 4,5-dihydropyrazoles and their thiazole hybrids as EGFR inhibitorsRiham F George, Eman M Samir, Mennatullah N Abdelhamed, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Factors affecting the pharmacokinetics of nifedipineA G Renwick, J Le Vie, V F Challenor, et al.
Pageof 75

Showing results (421-430 of 750) with videos related to

Sort By:
Pageof 75
The Journal of Organic Chemistry|May 4, 2016
Enantioselective Synthesis of 3,3-Difluoropyrrolidin-4-ol, a Valuable Building Block in Medicinal ChemistryChong Si, Kevin R Fales, Alicia Torrado, et al.
Elife|July 5, 2022
Single-cell glycomics analysis by CyTOF-Lec reveals glycan features defining cells differentially susceptible to HIVTongcui Ma, Matthew McGregor, Leila Giron, et al.
Future Medicinal Chemistry|September 24, 2019
Synthesis and anticancer activity of some pyrido[2,3-<i>d</i>]pyrimidine derivatives as apoptosis inducers and cyclin-dependent kinase inhibitorsSafinaz E-S Abbas, Riham F George, Eman M Samir, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2015
Synthesis and QSAR study of novel anti-inflammatory active mesalazine-metronidazole conjugatesRoman N Naumov, Siva S Panda, Adel S Girgis, et al.
Transplantation|September 1, 2011
Ganciclovir transiently attenuates murine cytomegalovirus-associated renal allograft inflammationMasako Shimamura, Ute Saunders, Brian Rha, et al.
Transplantation|February 7, 2001
Enhanced allograft survival induced by posttransplant donor spleen cell infusion occurs via a mechanism that is distinct from the mechanism of enhancement by donor bone marrowD R Goldstein, T Chang, S D Sweeney, et al.
British Journal of Clinical Pharmacology|April 1, 1991
Ethnic differences in the pharmacokinetics of oral nifedipineC H Ahsan, A G Renwick, B Macklin, et al.
Clinical Pharmacokinetics|September 1, 1986
Effects of ischaemic heart disease, Crohn's disease and antimicrobial therapy on the pharmacokinetics of sulphinpyrazoneH A Strong, R Angus, J Oates, et al.
Bioorganic Chemistry|November 1, 2018
Synthesis and anti-proliferative activity of some new quinoline based 4,5-dihydropyrazoles and their thiazole hybrids as EGFR inhibitorsRiham F George, Eman M Samir, Mennatullah N Abdelhamed, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Factors affecting the pharmacokinetics of nifedipineA G Renwick, J Le Vie, V F Challenor, et al.
Pageof 75